Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Gastrointestinal 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1CNS 1

Conditions

Pleural Effusion, Malignant 1Mesothelioma, Malignant 1

Interventions

Carboplatin 205pembrolizumab 169Pemetrexed 144Cisplatin 126Paclitaxel 78durvalumab 75osimertinib 70Nivolumab 68Docetaxel 66Specimen Handling 64atezolizumab 60Magnetic Resonance Spectroscopy 54Etoposide 47Gemcitabine 46Radiotherapy 45Radiosurgery 40130-nm albumin-bound paclitaxel 36Drug Therapy 33Bevacizumab 29Cetuximab 28Ipilimumab 27cemiplimab 25Taxes 24tislelizumab 21Immunoglobulin G 21Radiation 20Platinum 20Biopsy 20amivantamab 19Disulfides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pharmaceutical Preparations × Thoracic × 90 days × Clear all
NCT07443020 2026-04-07

RIOT 4B

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡